Overview
A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/09/11 | Phase 4 | Active, not recruiting | Anhui Provincial Hospital | ||
2024/08/16 | Phase 1 | Recruiting | Anhui Provincial Hospital |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| BioActive Nutritional, Inc. | 43857-0020 | ORAL | 6 [hp_X] in 1 mL | 5/14/2025 | |
| Deseret Biologicals, Inc. | 43742-2259 | ORAL | 8 [hp_X] in 1 mL | 4/8/2025 | |
| Parasitology Center Inc. | 70321-0003 | ORAL | 10 [hp_X] in 1 mL | 5/22/2025 | |
| Oncora Pharma, LLC | 85477-606 | ORAL | 5 mg in 1 1 | 9/5/2025 | |
| Jaymac Pharmaceutical | 64661-222 | ORAL | 8.3 ug in 1 1 | 9/18/2025 | |
| Parasitology Center, Inc. | 70321-0002 | ORAL | 8 [hp_C] in 1 mL | 5/22/2025 | |
| Deseret Biologicals, Inc. | 43742-1324 | ORAL | 6 [hp_C] in 1 mL | 5/27/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Genuine NAD+ | 372512 | Medicine | A | 8/9/2021 | |
| MELTMED Regenerate | 413150 | Medicine | A | 7/10/2023 | |
| A·V·I NAD+ | 378148 | Medicine | A | 11/17/2021 | |
| NAD+ AAA | 495386 | Medicine | A | 6/30/2025 | |
| BLACKSOILBIO NAD + Q10 | 495365 | Biotech Co | Medicine | A | 6/30/2025 |
| Cellife NADH | 409090 | Cellife Health Products Pty Ltd | Medicine | A | 5/17/2023 |
| SL-NAD+ 100mg | 469505 | Medicine | A | 11/20/2024 | |
| Entity SL-NAD+ 100mg | 459386 | Medicine | A | 8/13/2024 | |
| SL-NAD+ | 371660 | Medicine | A | 7/26/2021 | |
| SL NAD+ | 451685 | Medicine | A | 6/11/2024 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| CUTISITUM | 02236489 | Liquid - Oral | 10 D | 2/6/1998 | |
| UBICOENZYME | 02236503 | Liquid - Oral | 8 D | 2/6/1998 | |
| DISCOMPEEL | 02236490 | Liquid - Oral | 10 D / D | 2/6/1998 | |
| HEPAR COMPOSITUM | 02236496 | Liquid - Oral | 12 D | 2/6/1998 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.